---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-085425"
form_type: "8-K"
ticker: "CGEM"
cik: "0001789972"
company_name: "Cullinan Therapeutics, Inc."
filed_at: "2025-06-12T23:59:59+00:00"
generated_at: "2026-05-19T10:58:53.635575+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Cullinan Therapeutics annual meeting results: all proposals pass, directors elected

## Summary
- Elected Class II directors: Anthony Rosenberg, David P. Ryan, Mary Thistle; each received >47M votes for.
- Ratified KPMG as independent auditor for FY2025: 51.9M for, 157K against, 14K abstain.
- Approved advisory say-on-pay on executive compensation: 46.96M for, 2.00M against, 14.7K abstain.
- Stockholders voted for annual say-on-pay frequency (48.5M for 1 year); board adopts annual vote.

## SEC filing metadata
- accession: 0000950170-25-085425
- form_type: 8-K
- ticker: CGEM
- cik: 0001789972
- company_name: Cullinan Therapeutics, Inc.
- filed_at: 2025-06-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1789972/000095017025085425/0000950170-25-085425-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1789972/000095017025085425/cgem-20250612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-085425
- JSON: https://secwatch.observer/filing/0000950170-25-085425.json
- Plain text: https://secwatch.observer/filing/0000950170-25-085425.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.